Pharmaceutical Technology
JUNE 14, 2023
Navigating the complexities of pharma and biotech packaging services can be difficult. Packaging trends The pharmaceutical contract packaging market is witnessing substantial growth.
Pharmaceutical Technology
AUGUST 16, 2022
Even giant pharma companies with large internal production capabilities are leaning on outsourcing to meet market demand for huge numbers of injectables, including high-value biologics and Covid-19 vaccines, according to a GlobalData analysis. Why do large and mega-cap sponsors outsource?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
MAY 26, 2023
Pharma company merger and acquisition (M&A) activity in the first half of 2023 has remained relatively low, consistent with the second half of last year, but investors predict deals will increase later in 2023. Experts at PWC, Goldman Sachs, and Morgan Stanley agree that pharma-related M&A is expected to pick up in 2023.
pharmaphorum
JUNE 11, 2021
The Philadelphia-based company said it had taken the decision to go down the biologics license application (BLA) route for Covaxin based on FDA feedback to the EUA data package it had submitted to the agency.
Drug Discovery World
AUGUST 5, 2022
An increasing number of academic groups, start-ups, biotechs and small pharma companies are turning to external consultants for professional programme management support and guidance to help them progress their ideas into medicines for patients. Why sponsors use external consultants.
Drug Discovery World
FEBRUARY 10, 2023
A good part of half of those are within pharma. The pharma companies that are based in Sweden, are international ones, and often have a marketing and commercial side but maybe not that drug development side that really brings that key focus area between the development and commercialisation.” It’s also a seal of quality.
Drug Discovery World
MARCH 29, 2023
The commission is looking to put more pressure on pharma companies to report such shortages, and to offer a drug’s marketing authorisation to another company before withdrawing it from the market. This looks like it may change shape in the future for the region, if the proposal put forward by the commission is adopted.
Expert insights. Personalized for you.
130 
Let's personalize your content